MENU
+Compare
APDN
Stock ticker: NASDAQ
AS OF
Jan 30 closing price
Price
$0.18
Change
+$0.01 (+5.88%)
Capitalization
7.13M

APDN Applied DNA Sciences Forecast, Technical & Fundamental Analysis

a provider of botanical deoxyribonucleic acid based security and authentication solutions

APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for APDN with price predictions
Jan 29, 2025

APDN sees its Stochastic Oscillator climbs out of oversold territory

On January 24, 2025, the Stochastic Oscillator for APDN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on APDN as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for APDN turned negative on January 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

APDN moved below its 50-day moving average on January 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for APDN crossed bearishly below the 50-day moving average on January 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APDN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.685) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.619) is also within normal values, averaging (41.167).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. APDN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APDN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

APDN is expected to report earnings to fall 1,057.45% to -450 cents per share on May 09

Applied DNA Sciences APDN Stock Earnings Reports
Q1'24
Est.
$-4.50
Q2'24
Beat
by $4.17
Q4'23
Beat
by $0.18
Q3'23
Est.
$-0.26
Q2'23
Est.
$-0.24
The last earnings report on August 08 showed earnings per share of 46 cents, beating the estimate of -370 cents. With 793.61K shares outstanding, the current market capitalization sits at 7.13M.
A.I. Advisor
published General Information

General Information

a provider of botanical deoxyribonucleic acid based security and authentication solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Information Technology Services
Address
50 Health Sciences Drive
Phone
+1 631 240-8800
Employees
55
Web
https://www.adnas.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BJ99.991.08
+1.09%
BJs Wholesale Club Holdings
SHIP7.020.07
+0.93%
Seanergy Maritime Holdings Corp
EGBN26.050.02
+0.08%
Eagle Bancorp
NARI79.69-0.01
-0.01%
Inari Medical
BOXL0.85-0.03
-3.75%
Boxlight Corp

APDN and Stocks

Correlation & Price change

A.I.dvisor tells us that APDN and UFPT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APDN and UFPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APDN
1D Price
Change %
APDN100%
+3.73%
UFPT - APDN
29%
Poorly correlated
+0.56%
POAI - APDN
28%
Poorly correlated
+7.64%
PRPO - APDN
27%
Poorly correlated
+2.48%
ATEC - APDN
24%
Poorly correlated
-2.57%
CODX - APDN
24%
Poorly correlated
-0.21%
More